$RTSL
Rapid Therapeutic Science Laboratories, Inc.

2023 Q3 Form 10-Q Financial Statement

#000139390523000312 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $97.74K
YoY Change -3.34%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.993K
YoY Change 0.0%
% of Gross Profit
Operating Expenses $103.7K
YoY Change -19.2%
Operating Profit -$103.7K
YoY Change -19.2%
Interest Expense $60.83K
YoY Change -92.05%
% of Operating Profit
Other Income/Expense, Net $150.2K
YoY Change 64.04%
Pretax Income $46.42K
YoY Change -226.02%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $46.42K
YoY Change -226.02%
Net Earnings / Revenue
Basic Earnings Per Share $0.01
Diluted Earnings Per Share $0.01
COMMON SHARES
Basic Shares Outstanding 8.832M shares 8.082M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.160K
YoY Change -98.07%
Cash & Equivalents $2.160K
Short-Term Investments
Other Short-Term Assets $58.15K
YoY Change -13.08%
Inventory $175.0K
Prepaid Expenses $58.15K
Receivables
Other Receivables
Total Short-Term Assets $317.9K
YoY Change -10.23%
LONG-TERM ASSETS
Property, Plant & Equipment $1.289M
YoY Change -15.39%
Goodwill
YoY Change
Intangibles $170.1K
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.756M
YoY Change -15.39%
TOTAL ASSETS
Total Short-Term Assets $317.9K
Total Long-Term Assets $1.756M
Total Assets $2.074M
YoY Change -14.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $770.0K
YoY Change 9.27%
Accrued Expenses $274.5K
YoY Change 73.46%
Deferred Revenue
YoY Change
Short-Term Debt $2.456M
YoY Change 10.15%
Long-Term Debt Due $841.6K
YoY Change 19.08%
Total Short-Term Liabilities $4.426M
YoY Change -8.95%
LONG-TERM LIABILITIES
Long-Term Debt $150.0K
YoY Change 0.0%
Other Long-Term Liabilities $237.9K
YoY Change -29.73%
Total Long-Term Liabilities $387.9K
YoY Change -20.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.426M
Total Long-Term Liabilities $387.9K
Total Liabilities $4.813M
YoY Change -10.01%
SHAREHOLDERS EQUITY
Retained Earnings -$10.08M
YoY Change -0.59%
Common Stock $8.832K
YoY Change 14.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $337.3K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$2.739M
YoY Change
Total Liabilities & Shareholders Equity $2.074M
YoY Change -14.64%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $46.42K
YoY Change -226.02%
Depreciation, Depletion And Amortization $5.993K
YoY Change 0.0%
Cash From Operating Activities -$7.330K
YoY Change -97.07%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.090K
YoY Change -102.43%
NET CHANGE
Cash From Operating Activities -7.330K
Cash From Investing Activities 0.000
Cash From Financing Activities -8.090K
Net Change In Cash -15.42K
YoY Change -119.47%
FREE CASH FLOW
Cash From Operating Activities -$7.330K
Capital Expenditures $0.00
Free Cash Flow -$7.330K
YoY Change -97.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55018
dei Entity Registrant Name
EntityRegistrantName
Rapid Therapeutic Science Laboratories, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2111820
dei Entity Address Address Line1
EntityAddressAddressLine1
558 County Road 472
dei Entity Address City Or Town
EntityAddressCityOrTown
De Leon
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76444
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
497-6059
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8832251 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2160 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
82529 usd
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
0 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
175047 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
175047 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
58146 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
58146 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
317882 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
233193 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1354072 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1564503 usd
CY2023Q2 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
65313 usd
CY2022Q4 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
53327 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1288759 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1511176 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340136 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
170075 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
170075 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
297619 usd
CY2023Q2 us-gaap Assets
Assets
2074335 usd
CY2022Q4 us-gaap Assets
Assets
2254580 usd
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
769957 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
891408 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
841560 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
820602 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2455791 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2481333 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
173856 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
124736 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
100650 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
98509 usd
CY2023Q2 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
30195 usd
CY2022Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
508593 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
53568 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
40647 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4425577 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4965828 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
150000 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
150000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
237892 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
280235 usd
CY2023Q2 us-gaap Liabilities
Liabilities
4813469 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5396063 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8832251 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7764594 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
8832 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7763 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7667829 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7504242 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10078456 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10316149 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
337339 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
337339 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2739134 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3141483 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2074335 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2254580 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
21259 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
97739 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
122382 usd
CY2023Q2 us-gaap Depreciation
Depreciation
5993 usd
CY2022Q2 us-gaap Depreciation
Depreciation
5993 usd
CY2023Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
103732 usd
CY2022Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
128375 usd
CY2023Q2 fil Gain Loss On Valuation Of Warrant Liability
GainLossOnValuationOfWarrantLiability
128456 usd
CY2022Q2 fil Gain Loss On Valuation Of Warrant Liability
GainLossOnValuationOfWarrantLiability
857127 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
60831 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
765590 usd
CY2023Q2 fil Refund Of Prior Year Employer Taxes
RefundOfPriorYearEmployerTaxes
82529 usd
CY2022Q2 fil Refund Of Prior Year Employer Taxes
RefundOfPriorYearEmployerTaxes
0 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
150154 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
91537 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
46422 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36838 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
46422 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-36838 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8318055 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7746687 shares
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
42517 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
190040 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
905782 usd
us-gaap Depreciation
Depreciation
11986 usd
us-gaap Depreciation
Depreciation
11986 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
202026 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
917768 usd
fil Gain Loss On Valuation Of Warrant Liability
GainLossOnValuationOfWarrantLiability
529047 usd
fil Gain Loss On Valuation Of Warrant Liability
GainLossOnValuationOfWarrantLiability
780082 usd
us-gaap Interest Expense
InterestExpense
171857 usd
us-gaap Interest Expense
InterestExpense
1478903 usd
fil Refund Of Prior Year Employer Taxes
RefundOfPriorYearEmployerTaxes
82529 usd
fil Refund Of Prior Year Employer Taxes
RefundOfPriorYearEmployerTaxes
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
439719 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-698821 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
237693 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1616589 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Profit Loss
ProfitLoss
237693 usd
us-gaap Profit Loss
ProfitLoss
-1616589 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8149758 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7745759 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3141483 usd
CY2023Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
112656 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
191271 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2837556 usd
CY2023Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
12000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
40000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
46422 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2739134 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1381757 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1579751 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2941508 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
59210 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-36838 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2919136 usd
us-gaap Profit Loss
ProfitLoss
237693 usd
us-gaap Profit Loss
ProfitLoss
-1616589 usd
fil Gain Loss On Valuation Of Warrant Liability
GainLossOnValuationOfWarrantLiability
529047 usd
fil Gain Loss On Valuation Of Warrant Liability
GainLossOnValuationOfWarrantLiability
780082 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
83355 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1342180 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
30329 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
79210 usd
us-gaap Depreciation
Depreciation
11986 usd
us-gaap Depreciation
Depreciation
11986 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
42517 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
42517 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
58659 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
0 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
82529 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-6608 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
48778 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
244658 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
49120 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
35265 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49139 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-634247 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
354800 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-354800 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
40000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
423000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
50000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
525127 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
38701 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
39400 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51299 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
908727 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2160 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-80320 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
192484 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2160 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
112164 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
3352 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Debt Instrument Increase Decrease Other Net
DebtInstrumentIncreaseDecreaseOtherNet
124656 usd
us-gaap Debt Instrument Increase Decrease Other Net
DebtInstrumentIncreaseDecreaseOtherNet
0 usd
fil Accounts Payable For Additions To Property And Equipment
AccountsPayableForAdditionsToPropertyAndEquipment
-210431 usd
fil Accounts Payable For Additions To Property And Equipment
AccountsPayableForAdditionsToPropertyAndEquipment
307879 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
111358 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
100650 usd
CY2022Q1 fil Common Stock Authorized Increase
CommonStockAuthorizedIncrease
800000000 shares
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
237892 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
297619 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
338542 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
237892 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;text-indent:36pt;text-align:justify"><i>Use of Estimates</i> - The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period.</p> <p style="font:10pt Times New Roman;margin:0;text-indent:36pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:36pt;text-align:justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.</p>
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10078456 usd
CY2023Q2 us-gaap Capital
Capital
4107695 usd
CY2023Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.05 pure
CY2020Q1 fil Common Stock Authorized Increase
CommonStockAuthorizedIncrease
750000000 shares
CY2022Q2 fil Common Stock Authorized Increase
CommonStockAuthorizedIncrease
800000000 shares
CY2022Q1 fil Preferred Stock Share Increase
PreferredStockShareIncrease
100000000 shares
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
400000 shares
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.10
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
40000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1354072 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1564503 usd
CY2023Q2 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
65313 usd
CY2022Q4 us-gaap Property Plant And Equipment Owned Accumulated Depreciation
PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
53327 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1288759 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1511176 usd
CY2023Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
3447352 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
3451935 usd
CY2023Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
3297352 usd
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
3301935 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
150000 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
150000 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
44972 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
102792 usd
CY2023Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
107075 usd
CY2023Q2 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
110038 usd
CY2023Q2 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
82529 usd
us-gaap Noninterest Expense Commission Expense
NoninterestExpenseCommissionExpense
27509 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001393905-23-000312-index-headers.html Edgar Link pending
0001393905-23-000312-index.html Edgar Link pending
0001393905-23-000312.txt Edgar Link pending
0001393905-23-000312-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rtsl-20230630.htm Edgar Link pending
rtsl-20230630.xsd Edgar Link pending
rtsl10q_1.jpg Edgar Link pending
rtsl_ex311.htm Edgar Link pending
rtsl_ex312.htm Edgar Link pending
rtsl_ex321.htm Edgar Link pending
rtsl_ex322.htm Edgar Link pending
Show.js Edgar Link pending
rtsl-20230630_cal.xml Edgar Link unprocessable
rtsl-20230630_def.xml Edgar Link unprocessable
rtsl-20230630_lab.xml Edgar Link unprocessable
rtsl-20230630_pre.xml Edgar Link unprocessable
rtsl-20230630_htm.xml Edgar Link completed